View all research projects
Research project

Production of Technology Assessment Reviews (TARs) for the National Institute of Health Research (NIHR) 2022-2027

Staff

Lead researchers

Professor Joanne Lord

Director (SHTAC)
Research interests
  • Joanne has research interests in health economic evaluation and decision modelling.
  • She has worked on a wide range of applied cost-effectiveness studies, including:
  • a review of newborn screening for inborn errors of metabolism;trials of diagnosis, patient ed…
Connect with Joanne

Email: J.Lord@soton.ac.uk

Other researchers

Dr Jonathan Shepherd BA (Hons), MPhil, PhD

Principal Research Fellow
Connect with Jonathan

Email: Jonny.Shepherd@soton.ac.uk

Collaborating research institutes, centres and groups

Research outputs

Avelumab with axitinib for untreated advanced renal cell carcinoma (MA review of TA645)
Asyl Hawa, Jo Picot, Lois Woods, Ines Ribeiro & Joanne Lord, 2026
Type: report
Deuruxolitinib for treating severe alopecia areata: a cost-comparison technology appraisal
Emma Maund, Mary Onoja, Joanne Lord & Jonathan Shepherd, 2026
Type: report
Lisocabtagene maraleucel for treating relapsed or refractory large B-cell lymphoma after 2 or more lines of systemic treatments.
Geoff Frampton, Lois Woods, Asyl Hawa, Keith Cooper & David Alexander Scott, 2026
Type: report
Home-testing devices for diagnosing obstructive sleep apnoea hypopnoea syndrome: a systematic review and economic evaluation
Jaime Peters, Jonathan Shepherd, Emma Maund, Bogdan Grigore, Lois Woods, Joanne Lord, David Alexander Scott & Chris Hyde, 2025, Health Technology Assessment
DOI: 10.3310/GJJS3014
Type: article
Glofitamab with gemcitabine and oxaliplatin for treating relapsed or refractory diffuse large B-cell lymphoma
Fay Chinnery, Emma Maund, Keith Cooper, David Alexander Scott & Geoff Frampton, 2025
Type: report
Elacestrant for treating oestrogen receptor-positive, HER2-negative advanced breast cancer with an ESR1 mutation after at least 1 endocrine treatment [ID6225]
Emma Maund, Marcia Takahashi, Joanne Lord & Jonathan Shepherd, 2025
Type: report
Daratumumab with bortezomib, lenalidomide and dexamethasone for untreated multiple myeloma when a stem cell transplant is unsuitable: a single technology appraisal
Neelam Kalita, Lois Woods, Fay Chinnery, David Alexander Scott & Jonathan Shepherd, 2025
Type: report